Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
Clinical Pediatrics
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (13)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Bothwell, J. E.
Right arrow Articles by Salisbury, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bothwell, J. E.
Right arrow Articles by Salisbury, S.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Vertebral Fractures in Boys with Duchenne Muscular Dystrophy

J. E. Bothwell, MB BCh MRCP(UK), MRCPCH

Royal Belfast Hospital for Sick Children, Northern Ireland

K. E. Gordon, MD, FRCP(C)

J. M. Dooley, MB, FRCP(C)

J. Mac Sween, RN

Division of Pediatric Neurology; Pediatric Endocrinology, IWK Health Centre, Nova Scotia, Canada

E. A. Cummings, MD, FRCP(C)

S. Salisbury, MD, MRCP(C)

Division of Pediatric Endocrinology, IWK Health Centre, Nova Scotia, Canada

Osteoporosis causes significant morbidity for boys with Duchenne muscular dystrophy. Corticosteroid therapy given to prolong mobility may increase the rate of osteoporosis and risk of fracture. This study of 33 boys with Duchenne muscular dystrophy determined retrospectively the incidence of vertebral fractures particularly after initiation of corticosteroids. A latency period of 40 months after commencement of steroids occurred before the first vertebral fracture appeared. However, by 100 months of treatment approximately 75% had sustained a vertebral fracture.

Clinical Pediatrics, Vol. 42, No. 4, 353-356 (2003)
DOI: 10.1177/000992280304200408
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 NeurologyHome page
W. M. King, R. Ruttencutter, H. N. Nagaraja, V. Matkovic, J. Landoll, C. Hoyle, J. R. Mendell, and J. T. Kissel
Orthopedic outcomes of long-term daily corticosteroid treatment in Duchenne muscular dystrophy
Neurology, May 8, 2007; 68(19): 1607 - 1613.
[Abstract] [Full Text] [PDF]